Capital raised by Antlia Bioscience
1 Form D filing · first filed May 2026 · Encinitas, CA
Director
Listed on Antlia Bioscience's Form D filings
Martin Taylor is on file as Director at Antlia Bioscience in Encinitas, CA. Antlia Bioscience has 1 Form D filing on record, $6.0M raised in total.
A preclinical therapeutic program applying XL-protein's PASylation technology to a cardiovascular peptide, extending its plasma half-life so it can be developed as a chronic treatment for heart failure.
